AUM CAPITAL (Your trust is our wealth)

facebook twitter linkedin
Careers

Market info

CIPLA LTD.

NSE : CIPLABSE : 500087ISIN CODE : INE059A01026Industry : Pharmaceuticals & DrugsHouse : Cipla
BSE1450.00-11 (-0.75 %)
PREV CLOSE (Rs.) 1461.00
OPEN PRICE (Rs.) 1438.70
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 25746
TODAY'S LOW / HIGH (Rs.)1438.70 1473.85
52 WK LOW / HIGH (Rs.)1165.55 1672.2
NSE1450.00-8.8 (-0.6 %)
PREV CLOSE( Rs. ) 1458.80
OPEN PRICE (Rs.) 1457.50
BID PRICE (QTY) 1450.00 (95)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 784917
TODAY'S LOW / HIGH(Rs.) 1449.20 1474.30
52 WK LOW / HIGH (Rs.)1165.7 1673
Home Market Info & ResearchCompany ProfileSmart Quotes
BSE NSE
1D 1M 3M 1Y 3Y 5Y
Trade Value (Rs. in Lacs)
375.98
Dividend Yield(%)
0.90
TTM EPS (Rs.)
38.05
P/E Ratio
38.10
Book Value (Rs.)
433.26
Face Value (Rs.)
2
MCap (Rs. in Mn)
1171387.09
Price/Earning (TTM)
30.93
Price/Sales (TTM)
6.78
Price/Book (MRQ)
3.35
PAT Margin (%)
17.52
ROCE (%)
14.04
Incorporation Year : 17-08 1935

Management Info :

Y K Hamied - Chairman Achin Gupta - Managing Director

Registered Office :

Address : Cipla House, Peninsula Business Park,Ganpatrao Kadam Marg,Lower Parel,
Mumbai,
Maharashtra-400013

Phone : 022-24826000 / 41916000

Website : www.cipla.com

Registrars Details :

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, Luxembourg
04Aug Cipla informs about update
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosur..
04Aug Cipla's arm gets EIR for manufacturing
Cipla's wholly-owned subsidiary -- InvaGen Pharmaceuticals, Inc. (InvaGe..
28Jul Cipla gets USFDA’s approval for Generi
Cipla has received U.S. Food and Drug Administration (USFDA) approval fo..
more
QTR Jun 26 ANNUAL 26
Net Profit8621.635151.8
Gross Profit 11536.2 46359.4
Operating Profit 13286.9 55890.4
Net Sales 50776.8 189799.5
more
Rs. in Millions
Kwality Pharma (BSE)
 3444.75 (3.53%)
M.Cap (Rs. in Cr)3574.34
Neuland Laboratories (BSE)
 23311.50 (0.38%)
M.Cap (Rs. in Cr)29908.40
Ajanta Pharma (BSE)
 3675.15 (1.64%)
M.Cap (Rs. in Cr)45924.32
Fredun Pharma (BSE)
 1547.75 (3.33%)
M.Cap (Rs. in Cr)2559.68
PROMOTERS
29.21%
MUTUAL FUNDS/UTI
20.56%
NON-INSTITUTION
15.95%
FI/BANKS/INSURANCE
11.86%
GOVERNMENT
0%
FII
0%
more
CLOSE X

Filling complaints on SCORES Easy & quick

  • > Register on SCORES portal
  • > Mandatory details for filling complaints on SCORES
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • > Benefits:
    • Effective communication
    • Speedy redressal of the grievances